We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Pollution Adds to Heart Risk in the Elderly

By HospiMedica staff writers
Posted on 31 Mar 2006
A new study shows that short-term exposure to fine-particle air pollution emissions significantly increases the risk for cardiovascular and respiratory disease among people over 65 years of age. More...


Researchers at the Johns Hopkins Bloomberg School of Public Health (Baltimore, MD, USA) conducted a fine-particle analysis on 11.5 million people over 65 who lived in 204 U.S. counties. Using billing records for 1999-2002, they tracked daily counts of hospital admissions for a range of medical conditions. They then obtained daily measurements of fine particle concentrations from a network of air monitoring stations.

The study results showed that small increases in fine-particle air pollution from such sources as motor vehicle exhaust and power plant emissions resulted in increased hospital admissions for heart and vascular disease, heart failure, chronic obstructive pulmonary disease, and respiratory infection. The study results were published in the March 8, 2006, issue of the Journal of the American Medical Association (JAMA).

When we analyzed the data for heart failure, we observed a 1.28% increase in admissions for each 10 mg per cubic meter increase in fine-particle pollution, said Francesca Dominici, Ph.D., an associate professor of biostatistics at Johns Hopkins and lead author of the study. Most of these admissions increases occurred the same day as the rise in fine-particle concentration, which suggests a short lag time between the change in pollution and the subjects' response.

According to the study, fine particles pose a significant health problem because they penetrate deep into the lungs, and some may get into the bloodstream, affecting cardiovascular and respiratory health. The findings underscore the need for an air quality standard that adequately protects respiratory health, the authors concluded.



Related Links:
Johns Hopkins Bloomberg School of Public Health

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.